Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis

Liver Transplantation

Volumn 14, Issue 6, 2008, Pages 837-844

  Huo, Teh Ia ^a,b   Lin, Han Chieh ^a,b   Huo, Samantha C ^c   Lee, Pui Ching ^a   Wu, Jaw Ching ^a,b   Lee, Fa Yauh ^a,b   Hou, Ming Chih ^a,b   Lee, Shou Dong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM;

ACCURACY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BACTERIAL PERITONITIS; CONTROLLED STUDY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SODIUM BLOOD LEVEL; STATISTICAL SIGNIFICANCE; VARICOSIS;

AGED; AREA UNDER CURVE; FEMALE; GASTROENTEROLOGY; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SODIUM; TREATMENT OUTCOME;

EID: 42149119733     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21439     Document Type: Article

References (44)

1. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003;124: 91-96.
2. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, et al. Model for End Stage Liver Disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40:897-903.
3. Salerno F, Merli M, Cazzaniga M, Valeriano V, Rossi P, Lovaria A, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002;36:494-500.
4. Freeman RB, Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM. Improving liver allocation: MELD and PELD. Am J Transplant 2004;(suppl 9):114-131.
5. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001;7:567-580.
6. Olthoff KM, Brown RS Jr, Delmonico FL, Freeman RB, McDiarmid SV, Merion RM, et al. Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. Liver Transpl 2004;10(suppl 2):A6-A22.
7. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz Rr, Sanyal AJ, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004;40:802-810.
8. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005;41: 32-39.
9. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005;11:336-343.
10. Porcel A, Diaz F, Rendon P, Macías M, Martín-Herrera L, Girón-González JA. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med 2002;162: 323-328.
11. Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 2003;38(suppl 1):S69-S89.
12. Ginès A, Escorsell A, Ginès P, Saló J, Jiménez W, Inglada L, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993;105:229-236.
13. Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quintó L, Ventura PJ, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001;34:46-52.
14. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130:1652-1660.
15. Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Ploner M, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007;13: 1174-1180.
16. Huo TI, Wang YW, Yang YY, Lin HC, Lee PC, Hou MC, et al. Model for End-Stage Liver Disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Liver Int 2007;27:498-506.
17. Wong VW, Chim AM, Wong GL, Sung JJ, Chan HL. Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B. Liver Transpl 2007;13:1228-1235.
18. Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, et al. Different Model for End-Stage Liver Disease score block distributions may have a variable ability for outcome prediction. Transplantation 2005;80:1414-1418.
19. Hou MC, Lin HC, Lee FY, Chang FY, Lee SD. Recurrence of esophageal varices following endoscopic treatment and its impact on rebleeding: comparison of sclerotherapy and ligation. J Hepatol 2000;32:202-208.
20. Hou MC, Lin HC, Kuo BI, Chen CH, Lee FY, Lee SD. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial. Hepatology 1995; 21:1517-1522.
21. Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000;32:142-153.
22. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-721.
23. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843.
24. Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005;41:353-358.
25. Freeman RB. Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection. Liver Transpl 2004;10(suppl 2):S2-S3.
26. de la Mata M, Cuende N, Huet J, Bernardos A, Ferrón JA, Santoyo J, et al. Model for End-Stage Liver Disease score-based allocation of donors for liver transplantation: a Spanish multicenter experience. Transplantation 2006; 82:1429-1435.
27. Ahmad J, Downey KK, Akoad M, Cacciarelli TV. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans. Liver Transpl 2007;13:1564-1569.
28. Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, et al. Evaluation of the increase in Model For End-Stage Liver Disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol 2005;42:826-832.
29. Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, et al. Correlation and comparison of the Model for End-Stage Liver Disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis. J Clin Gastroenterol 2007;41:706-712.
30. Schepke M, Roth F, Fimmers R, Brensing KA, Sudhop T, Schild HH, et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003;98:1167-1174.
31. Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Bisceglie AM. The safety of intra-abdominal surgery in patients with cirrhosis: Model for End-Stage Liver Disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. Arch Surg 2005;140:650-654.
32. Farnsworth N, Fagan SP, Berger DH, Awad SS. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 2004;188:580-583.
33. Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL. Model for End-Stage Liver Disease (MELD) predicts non-transplant surgical mortality in patients with cirrhosis. Ann Surg 2005;242:244-251.
34. Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G, et al. Impact of Model for End-Stage Liver Disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 2006;12:966-971.
35. Londoño MC, Cárdenas A, Guevara M, Quintó L, de Las Heras D, Navasa M, et al. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut 2007;56:1283-1290.
36. Obstein KL, Campbell MS, Reddy KR, Yang YX. Association between Model for End-Stage Liver Disease and spontaneous bacterial peritonitis. Am J Gastroenterol 2007; 102:2732-2736.
37. Fernández J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 2007;133: 818-824.
38. Stewart CA, Malinchoc M, Kim WR, Kamath PS. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 2007;13:1366-1371.
39. Huo TI, Lin HC, Wu JC, Hou MC, Lee FY, Lee PC, et al. Limitation of the Model for End-Stage Liver Disease for outcome prediction in patients with cirrhosis-related complications. Clin Transplant 2006;20:188-194.
40. Hartleb M, Boldys H, Rudzki K, Nowak A, Nowak S. Portal shunting in inferior mesenteric vein in cirrhosis: correlation with hemorrhage from esophageal varices. Am J Gastroenterol 1994;89:863-867.
41. Chan HL, Chim AM, Lau JT, Hui AY, Wong VW, Sung JJ. Evaluation of Model for End-Stage Liver Disease for prediction of mortality in decompensated chronic hepatitis B. Am J Gastroenterol 2006;101:1516-1523.
42. Dai CY, Yu ML, Hsieh MY, Lee LP, Hou NJ, Huang JF, et al. Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation. Liver Int 2007;27:1364-1370.
43. Huo TI, Lin HC, Huang YH, Wu JC, Chiang JH, Lee PC, et al. The Model for End-Stage Liver Disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy. Cancer 2006;107:141-148.
44. Huo TI, Huang YH, Lin HC, Wu JC, Chiang JH, Lee PC, et al. Proposal of a modified Cancer of the Liver Italian Program staging system based on the Model for End-Stage Liver Disease for patients with hepatocellular carcinoma undergoing loco-regional therapy. Am J Gastroenterol 2006;101:975-982.